Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis.

Qu, Zhen; Wu, Junhua; Wu, Junyi; Ji, Anlai; Qiang, Guanghui; Jiang, Yong; Jiang, Chunping; Ding, Yitao

Qu, Zhen; Wu, Junhua; Wu, Junyi; Ji, Anlai; Qiang, Guanghui; Jiang, Yong; Jiang, Chunping; Ding, Yitao.

Afiliação

Qu Z; Department of Hepatobiliary Surgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu Province, China.
Wu J; Department of Hepatobiliary Surgery, The First People's Hospital of Changzhou, The Third Hospital Affiliated to Soochow University, Changzhou, Jiangsu, China.
Wu J; Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu Province, China.
Ji A; Department of Hepatobiliary Surgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu Province, China.
Qiang G; Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu Province, China.
Jiang Y; Department of General Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, China.
Jiang C; Department of Hepatobiliary Surgery, Drum Tower Clinical College of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Ding Y; Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, Jiangsu Province, China.

Oncotarget ; 8(46): 80666-80678, 2017 Oct 06.

Article em En | MEDLINE | ID: mdl-29113334

Palavras-chave

ERK; HCC; biomarker; exosomal miRNA-665; tumor growth

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google